GH GHRS Q1 2026 Results Miss Estimates EPS 031 vs 028 Adv Biomed ADVB Stock Today Rallies 451 Resistance at 486 20260515 Laos Tourism Sector Gains Momentum as Luang Prabang Attracts Global Travelers Wholesale Inflation Surges 6 in April Marking Sharpest Annual Increase Since 2022 Bipartisan Housing Affordability Bill Passes House New Rules for Corporate Investors US Natural Gas Futures Decline as Warmer Weather Forecasts Reduce Heating Demand Powell Vows No Shadow Chair Role but Return of Former Fed Leader Warsh Could Stir Tensions Russias Yolka Drone Interceptor Operational Limits Signal Potential Defense Market Shifts Junk Debt Rally Raises Concerns Over Investor Complacency Amid Growing Risks Could AI Infrastructure and Energy Plays Surpass Nvidia Returns ONEW Q1 2026 Earnings Deep EPS Miss Overshadows Modest Share Gain Kimball Electronics Q1 2026 Earnings EPS Miss Disappoints but Stock Gains Amid Mixed Signals HTZ Q1 2026 Earnings NarrowerThanExpected Loss Boosts Sentiment CAPL Q1 2026 Earnings Strong EPS Surprise Despite Challenging Environment Jack In The Box Inc JACK Q1 2026 Earnings EPS Slightly Misses Estimates Amid Operational Focus Gabelli Healthcare Wellness Trust GRX Edges Higher Amid Steady Trading Alarmcom Holdings ALRM Inches Higher as Stock Consolidates Near Support BuildABear Workshop BBW Holds Steady Near Support Amid Modest Pullback Intelligent Living Application Group ILAG Faces Selling Pressure as Shares Slide 53 Telecoms CEO Warns of European Vulnerability to US Dominance in Satellites and AI Elme Communities Q4 2025 Earnings Significant EPS Miss Reflects Challenging Operating Environment TechnologyDriven Healthcare Transformation Ushering a New Era of Medicine Small Mutual Fund Distributors Turn to Online Platforms to Manage GST Impact Niva Bupa Targets TopTwo Position in Retail Health Insurance Within Three Years Jobless Claims Remain Low Signaling Continued Labor Market Strength Alain Prost Injured in Home Raid Near Geneva Security Implications for HighProfile Figures Micron on Track for Best Month Since 1987 Yet Analysts See Room to Run Novartis Raises FullYear Sales and Profit Outlook Signaling Strong Operating Momentum